EGFR and breast carcinoma: This study also demonstrated that rhein has the potential to sensitize breast cancer cells to taxol by decreasing the levels of phospho-epidermal growth factor receptor (p-EGFR), thus unravelling the potential of this anthraquinone for the management of drug resistance in breast cancer cells [46].